Faculty

Share
Print
Share
Print
and/or
27 Faculty members found
Human Oncology & Pathogenesis Program
The Adrienne Boire Lab
Adrienne A. Boire, MD, PhD
Physician-scientist Adrienne Boire studies metastasis to the central nervous system.
Human Oncology & Pathogenesis Program
The Alan Hanash Lab
Alan M. Hanash, MD, PhD
Physician-scientist Alan Hanash studies transplant immunology and immune-mediated mechanisms of tissue damage and regeneration.
Human Oncology & Pathogenesis Program
Andrew Intlekofer Lab Group
Andrew M. Intlekofer, MD, PhD
Physician-scientist Andrew Intlekofer investigates why cancer cells depend on specific pathways of nutrient metabolism.
Human Oncology & Pathogenesis Program
The Charles Sawyers Lab
Charles L. Sawyers, MD
Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.
Human Oncology & Pathogenesis Program
The Christine Iacobuzio-Donahue Lab
Christine A. Iacobuzio-Donahue, MD, PhD
Physician-scientist Christine Iacobuzio-Donahue studies the genomics and cell biology of pancreatic and other solid tumors as it relates to subclonal evolution, tumor progression, and metastasis.
Human Oncology & Pathogenesis Program
The Christopher Klebanoff Lab
Christopher A. Klebanoff, MD
Physician-scientist Christopher A. Klebanoff studies T cell immunobiology with an emphasis on adoptive T cell immunotherapy for the treatment of solid malignancies.
Human Oncology & Pathogenesis Program
Chrysothemis Brown, MBBS, PhD
The Brown Lab studies how the tissue environment shapes immune cell fate and function during early life immune development, inflammation, and cancer.
Human Oncology & Pathogenesis Program
The David Solit Lab
David B. Solit, MD
Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.
Human Oncology & Pathogenesis Program
The Cheng Lab
Emily H. Cheng, MD, PhD
Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer therapy, with primary emphasis on lung and kidney cancers.
Human Oncology & Pathogenesis Program
The Ingo Mellinghoff Lab
Ingo K. Mellinghoff, MD, FACP
Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.